Secondaries announced 8.30.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Atossa Genetics
Symbol: ATOS
Price: Last trade $3.46
Description: No re-offer range available
Trade Date: 8/31
Shares: TBD
Underwriter(s) Aegis Capital
Rating=Subscription Needed